Nature of the Disclosure

This is a regulatory disclosure made by Transpek Industry Limited to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the resignation of a Senior Management Personnel.

Key Event Details

Dr. Gurpreet Kaur, designated as Senior General Manager — Research & Development and Quality Control (Sr. General Manager — R&D and QC), has tendered her resignation from the company.

Dates of Action

  • Resignation Tendered: Monday, 13th July 2026.
  • Effective Relieving Date: At the close of business hours on Wednesday, 15th July 2026.

Reason for Resignation

The stated reason for resignation, as provided by Dr. Kaur and cited by the company, is "professional circumstances."

Parties Involved

  • Resigning Personnel: Dr. Gurpreet Kaur (Employee T. No. 10776), Head of Department R&D, designated as Senior Management Personnel.
  • Compliance Officer: Alak D. Vyas, Company Secretary & Compliance Officer (ACS: 31731).
  • Regulatory Recipient: BSE Limited.

Additional Information Provided

A detailed table of particulars as required by the SEBI circular is included in the filing:

  • Name: Dr. Gurpreet Kaur
  • Reason for change: Resigned as Sr. General Manager (R&D and QC) due to professional circumstances.
  • Date of cessation: Effective from the closure of business hours on 15/07/2026.
  • Brief profile (for appointment): Not Applicable (NA).
  • Disclosure of relationships between directors: Not Applicable.
  • Resignation Letter: Attached as Annexure B, containing detailed reasons for resignation.

The full resignation letter from Dr. Gurpreet Kaur addressed to the Managing Director is included. It reiterates the resignation date (13.07.2026), the request to be relieved by 15.07.2026, and the reason (professional circumstances). The letter expresses gratitude for the opportunities and wishes the team and company well for the future.

Financial Impact

Financial impact is not quantified in the disclosure.

Availability of Information

The intimation is also available on the company's website at www.transpek.com.